Latest Financials News

EP&T Global delivered a positive net operating cash inflow of $0.4 million in the December 2024 quarter, supported by an 11% increase in customer receipts and a $1 million private placement to back expansion plans.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

Golden Horse Minerals has swiftly completed its inaugural drilling campaign at Hakes Find shortly after its ASX debut, setting the stage for an active exploration year in 2025.

EZZ Life Science Holdings delivered a robust Q2 FY25 with a 16.6% increase in customer receipts and a 308% jump in operating cash flows, while gearing up for US market entry and expanding its global footprint.

Regal Investment Fund has updated its dividend announcement, confirming an actual ordinary dividend of AUD 0.10 per unit payable in March 2025. The distribution relates to the six-month period ending December 31, 2024.

Powerhouse Ventures Limited reports a robust quarterly performance with a notable uplift in net tangible assets to 10.4 cents per share, driven by strategic acquisitions and active investment management.

Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.

Orpheus Uranium Limited reports a productive December quarter marked by a successful $1.66 million capital raise, completion of a major gravity survey at Mount Douglas, and ongoing progress toward regulatory approvals for advanced uranium exploration.

Forbidden Foods Limited has more than doubled its group revenues in Q2 FY25 following the acquisition of Oat Milk Goodness, driven by expanded retail distribution and strong ecommerce growth.

Core Lithium Ltd reports solid progress on its Finniss Lithium Project, highlighting robust drilling results, a healthy balance sheet, and steady advancement of its restart study targeting a June 2025 completion.

Insignia Financial reported a robust 2.2% increase in Funds Under Management and Administration to $326.8 billion in 2Q25, underpinned by strong net inflows and strategic milestones including the IT separation from NAB and the unveiling of its Vision2030 growth strategy.

Praemium Limited reports a solid Q2 FY25 performance, with Funds Under Administration rising 4% to $30.2 billion and net inflows surging to $371 million, driven by strong momentum in its SMA and Powerwrap platforms.